Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nomination Committee appointed for the 2022 Annual General Meeting of Immunovia AB (Publ)

According to the instructions for the Nomination Committee of Immunovia AB (Publ) that were adopted at the Annual General Meeting on May 6, 2021, the Nomination Committee shall consist of four members. LUND, SWEDEN – The Nomination Committee, which is to be appointed for the period until a new Nomination Committee is appointed, shall consist of four members, of which three will be appointed by the Company's three largest shareholders in terms of voting, and the fourth shall be the Chairman of the Board. In the event that the Chairman of the Board is one of the three largest shareholders,

Invitation to conference call and web presentation of Cint Group Q3 2021 report

CEO Tom Buehlmann and CFO Joakim Andersson will present the Q3 2021 results through a telephone conference which will be held today, 25 October 2021 at 11.00 CEST. The conference call will also be webcast. Telephone numbersPlease make sure that you are connected to the phone conference by calling in and registering a few minutes before the conference begins. SE: +46 8-566 427 04 (no PIN required)UK: +44 333 300 9267 (no PIN required)US: +1 631 913 1422, PIN: 1763 3011#  Link to the live broadcast: webcast 

OCY06 - Notice of a written bondholder resolution

25 October 2021 - Ocean Yield ASA (the "Issuer") has today instructed Nordic Trustee AS as trustee for its perpetual hybrid callable bond issue with ISIN NO 0010861594 (OCY06) to issue a notice of a written bondholder resolution to consider certain amendments to the bond terms. The notice is attached to this release. As follows from the notice, bondholders together representing 72.55 per cent of the outstanding bonds have irrevocably undertaken to vote in favour of the proposal, meaning that the proposal will be adopted as proposed when such votes are received by the bond trustee. Arctic

Scandinavian ChemoTech has secured CE-marked electrodes for deep-seated tumours

Following successful final tests Scandinavian ChemoTech, along with its partner in electrode technology, has developed CE-marked treatment kits for deep-seated tumours.The Company's new treatment kits are primarily developed for the treatment of deep-seated tumours. These have now passed the important compatibility tests between the new electrodes and our TSE™ technology. These new kits are intended for use in both human and veterinary medicine. “It feels very good to have been able to secure access to CE-marked treatment kits even for deep-seated tumours. This enables us to now begin

OmniCar receives subscription and underwriting commitments in regards to warrants of series TO 2

The exercise period for OmniCar Holding AB:s (“OmniCar”) warrants of series TO 2 commences on November 15, 2021. The company can today announce that CEO Claus T. Hansen and a number of other warrant holders have agreed to enter into subscription commitments to exercise their respective warrants amounting to a total of 6,411,245 SEK. In addition, OmniCar has signed an agreement for a "top-down underwriting" up to 11,297,596 SEK, which together with the subscription commitments amounts to a total of 17,708,841 SEK. This means that OmniCar has received subscription and underwriting commitments

Re-admission of Ordinary shares

NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BREACH ANY APPLICABLE LAW OR REGULATION. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT. FOR IMMEDIATE RELEASE. 25 October 2021 EnQuest PLC  Re-admission of shares  EnQuest PLC ("EnQuest", or the "Company") is pleased to announce that, further to the announcement on 22 October 2021 regarding the completion of the acquisition of a 26.69% non-

Invitation to Eltel’s Q3 2021 report presentation

Eltel will publish its report for the period January-September 2021 on Wednesday 3 November 2021 at approximately 08:00 am CET. On the same day, we are inviting investors, analysts and media to a webcast starting at 10:00 am CET.The report for the period January-September 2021 will be presented live by Eltel’s President and CEO Casimir Lindholm and CFO Saila Miettinen-Lähde. The presentation will be held in English. Link to webcast: www.eltelgroup.com. During the presentation, there will be an opportunity to ask questions via the webcast. The presentation material as well as a

Trill Impact to build a cybersecurity leader to improve resilience against cybercrime

With an ambition to build a leading group that addresses the increasing need for cybersecurity services, Trill Impact has closed investments in Arctic Group AB (“Arctic Group”) and ID North AB (“ID North”) to form a strong platform for future expansion, jointly called European ID Security (“the Group”).In today’s world of digital transformation, the IT security of governments and enterprises is at risk, with identity theft, data breaches and insider threats among the top ten cyberthreats in the European Union. These are serious security concerns which have been further amplified during the

Beijer Ref acquires the Australian HVAC distributor Airstream

The global refrigeration wholesaler Beijer Ref has signed an agreement to acquire all the shares in the Australian distribution company Airstream.Airstream is an important manufacturer and distributor of ducting and associated fittings within air conditioning in Australia. The company was established in 2011 and consists of 14 employees. The majority of Airstream’s sales are made locally in Perth. Airstream has been operating as part of the iZone business, forming an integral part of their home solutions offering. Their annual sales amount to approximately SEK 40 million.   This

Mandatory notification of trade

Anooj Unarket, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 22nd October 2021, acquired interests in shares of Otello Corporation ASA. The balance of Anooj Unarket and related parties’ holdings after the transaction totals 26,029,404 shares. Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

Inhalations Sciences: US patent on XposeALI extended until 2034

(Stockholm October 25, 2021) Inhalation Sciences’ US patent protection on its in vitro Cell Culturing module XposeALI[®] has been extended until 2034. CEO Manoush Masarrat: “The US is a major market with enormous potential. XposeALI[®] offers US developers of inhaled pharmaceuticals an important competitive advantage.”ISAB’s first US patent application was submitted on September 25[th], 2013, when it was approved up until December 1[st], 2020 under the number 11054414. The patent has now been extended and is valid until 2034. ISAB’s XposeALI[® ]is a highly innovative and leading

Bravida Norway acquires Plato AS and strengthens its position in HVAC in Sunnmøre

Bravida acquires 100% of the shares in the HVAC company Plato AS in Sykkylven, which will be integrated in Bravida Norge AS. Plato AS has a turnover of approximately NOK 35 million and around 21 employees.Plato AS was founded in 1987 and is a HVAC contractor based in Sykkylven. The company’s main area of activity is installation and service work relating to HVAC systems, including heat pumps and plumbing. Its customers are mainly private companies, but also include consumers and public companies.  “We are very pleased to complete this acquisition. It will help us at Bravida to grow and

Wulff Group Plc’s Interim Report for January 1 – September 30, 2021

INTERIM REPORT OCTOBER 25, 2021 AT 9.30 A.M. This is a summary of Wulff Group Plc’s interim report for January-September 2021. Wulff Group’s interim report as a whole is attached as a PDF file to this stock exchange release and it is also available on the company’s website www.wulff.fi. The acquisition boosted growth and the positive earnings trend continued July 1–September 30, 2021 IN BRIEF · Net sales totalled EUR 24.2 million (12.4), increased by 95.1% · EBITDA and comparable EBITDA were EUR 1.7 million (1.3) · Operating profit (EBIT) and comparable operating profit (

Medivir Appoints Jens Lindberg as Chief Executive Officer

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the Board of Directors  has appointed Jens Lindberg as CEO of the company. Jens Lindberg has extensive experience from the pharmaceutical industry and the field of Oncology. He joins from Sedana Medical where he has been VP Commercial and acting CEO.   Jens Lindberg started his career in the pharmaceutical industry in 1995 as a sales representative for Astra, later AstraZeneca. During a 25-year span at AstraZeneca, Jens held numerous roles in Commercial & Investor Relations, spanning local & global

Wicket Gaming signs letter of intent to acquire Wegesrand with a turnover of EUR 2.5 million

25[th] October 2021 kl. 08:30 CEST Wicket Gaming AB ("Wicket Gaming" or the "Company") has signed a letter of intent with the German group Wegesrand Verwaltungsgesellschaft mbH ("Wegesrand") to acquire all shares in Wegesrand with subsidiaries for a total purchase price of approximately EUR 4 million. Most of the purchase price will be paid with newly issued shares in Wicket Gaming which will be subject to a lock-up commitment. The letter of intent gives Wicket Gaming an exclusive right to conduct due diligence with the aim of signing a final purchase agreement around the end of 2021/2022.

Volvo Cars sets fixed listing price at SEK 53 per share and amends offering size

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. Press release 25 October 2021Volvo Cars today announces the decision to amend the terms of its planned IPO on Nasdaq Stockholm. The update below follows the publication of Volvo Cars’ prospectus on 18 October 2021 and the announcement of Geely Sweden’s share conversion request on 22 October 2021. · The Board of Directors of Volvo Cars has today resolved to

BioStock: Sprint Bioscience receives research grant

Sprint Bioscience is constantly looking for highly interesting starting points for preclinical drug development projects, primarily in the field of cancer. Through a collaboration with Dr Julian Walfridsson at Karolinska Institutet, the company will identify new target proteins suitable for the treatment of blood cancer. The project has now been rewarded with a 2.5 MSEK research grant from the Swedish Foundation for Strategic Research.Read the full article at biostock.se:https://www.biostock.se/en/2021/10/sprint-bioscience-gets-research-grant/This is a press release from BioStock -

Gedea Biotech granted European Patent for its treatment pHyph for women with vaginal fungal infections

Patent now valid in two of the world’s largest markets, Europe and USA until 2037 Lund, Sweden, October 25, 2021. Swedish women’s health company Gedea Biotech today announced that the company has been granted a patent from the European Patent Office, covering the treatment of fungal infections with compound glucono-δ-lactone (GDL). The patent numbered EP 3 439 633 is valid in 36 European countries and can be kept in force until the 6th of April 2037. This follows previously announced patent rights valid in United States. Gedea Biotech has previously announced that the corresponding patent

2020 Bulkers Ltd. (2020) – Invitation to webcast and conference call Q3 2021 results

2020 Bulkers Ltd. will release its financial results for the third quarter of 2021 on Wednesday, October 27, 2021. A conference call and webcast will be held at 3:00 PM CET. The earnings report and presentation will be available from the Investor Relations section on www.2020bulkers.com on the same day. In order to listen to the presentation, you may do one of the following: Listen-only webcast (including the slide presentation): https://edge.media-server.com/mmc/p/6gzqv847 or you can click the “Webcast” link on www.2020bulkers.com/investor-relations/ Telephone conference Dial

Imfinzi improved survival in biliary tract cancer

25 October 2021 7:00 BST Imfinzi plus chemotherapy significantly improved overall survival in 1st-line advanced biliary tract cancer in TOPAZ-1 Phase III trial at interim analysis First immunotherapy combination to demonstrate superior clinical outcomesover standard of care in a global, randomised trial in this setting Positive high-level results from the TOPAZ-1 Phase III trial showed Imfinzi (durvalumab), in combination with standard-of-care chemotherapy, demonstrated a statistically significant and clinically meaningful overall survival (OS) benefit versus chemotherapy alone

Metso Outotec expands Lokotrack mobile series for aggregates

Metso Outotec Corporation’s press release on October 25, 2021, at 09:00 a.m. EESTMetso Outotec is launching two new models to the Lokotrack® mobile crushing and screening series. The new Lokotrack LT200HPX and Lokotrack LT220GP mobile cone crushers are compact but efficient units ideal for aggregate contractor customers, bringing up to 30% more capacity and added flexibility compared to earlier models. The new models will be premiered during Metso Outotec’s virtual studio events on 27[th] October, and in the new Lokotrack Liveroom 360 online experience together with services and parts

Indutrade acquires Italian company specialised in critical fluids handling

Indutrade has on 22 October 2021 signed an agreement to acquire all of the shares in the Italian company Italprotec Industries S.r.l., italprotec.com , with annual sales of approximately EUR 10 million (SEK 100 million). The agreement was signed after the market closed.Italprotec is a manufacturer and technical trader of engineered industrial products for handling of critical fluids. The offering includes hoses, connectors, single-use assemblies, valves, fittings, and heat exchangers. The products ensure purity, corrosion resistance, and protection in sterile

Herantis Pharma Announces Members of Scientific Advisory Board

Herantis Pharma Plc, Press Release, 25 October 2021 at 9:00 EEST Herantis Pharma Plc (“Herantis”), focusing on disease modifying therapies for debilitating neurodegenerative diseases, today announced the formation of a Scientific Advisory Board (SAB) comprised of industry leaders in CNS and neurodegenerative diseases, chaired by Dr. Anders Gersel Pedersen (as announcment September 14, 2021). The SAB will work cohesively with management to advance the company’s clinical development plan of rhCDNF (recombinant human CDNF) and HER-096 (xCDNF). “The prestigious group of scientific thought

There are no items matching the current filter
There are no more items matching the current filter
Back to top